MiRNA microarray kits and reagents market is experiencing robust growth driven by rising demand for precision diagnostics, biomarker discovery, and translational research. Expansion of oncology ...
Microarray experiments are widely used to quantify and compare gene expression on a large scale, it is therefore important that they are designed with care as aspects of their design will affect the ...
Agilent Technologies Inc and Paradigm Genetics Inc announced the commercial availability of an Arabidopsis microarray kit featuring more than 14,800 plant gene sequences derived from public domain ...
VANCOUVER, Nov. 27, 2012 /PRNewswire/ - Kinexus Bioinformatics Corporation, a world leader in functional proteomics research, announced today the release of its first Kinex TM antibody microarray kit ...
Agilent Technologies Inc. has introduced a new labelling and hybridization kit that simplifies the protocol for running miRNA profiling experiments on Agilent oligonucleotide microarrays. The new kit, ...
Breast phyllodes tumors are fibroepithelial neoplasms whose clinical behavior is difficult to predict on histology. There is relatively scant data on the role of biological markers. In this study, we ...
MiRNA microarray kits and reagents market is experiencing robust growth driven by rising demand for precision diagnostics, biomarker discovery, and translational research. Expansion of oncology ...
BOSTON--(BUSINESS WIRE)--Sengenics today announced the commercial launch of the i-Ome® Protein Array Kit. The i-Ome® Protein Array Kit contains slide-based, high density protein microarrays, comprised ...
The MarketWatch News Department was not involved in the creation of this content. MiRNA Microarray Kits And Reagents Market Surges to USD 2.45 Billion by 2033, Propelled by 8.5% CAGR - Verified Market ...
California-based Agilent Technologies Inc. and Paradigm Genetics Inc. have announced the commercial availability of an Arabidopsis microarray kit featuring more than 14,800 plant gene sequences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results